Can-Fite BioPharma CANF
NYSE CANF
$2.22 +0.00 (+0.00%)
As of: Sep 10, 2026 · 9:32 AM EDT

Can-Fite BioPharma (CANF) Invested Capital (2014)

Can-Fite BioPharma (CANF) posted Invested Capital of $29.1 million for Q4 2014.

Analysis

Can-Fite BioPharma (CANF) Invested Capital (2014) Analysis & Trends

Can-Fite BioPharma (CANF) has 1 years of Invested Capital data on file, last reported at $29.1 million in Q4 2014.

  • For the quarter ending Q4 2014, Invested Capital changed N/A year-over-year to $29.1 million; the trailing twelve-month figure through Dec 2014 stood at $29.1 million (changed N/A YoY), and the FY2014 full-year result was $29.1 million, changed N/A from the prior year.
  • Invested Capital was $29.1 million for Q4 2014 at Can-Fite BioPharma.
  • In the past five years, Invested Capital ranged from a high of $29.1 million in Q4 2014 to a low of $29.1 million in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 651.77 Bn 631.01 Bn 17.26 Bn 145.70 Bn
2 AbbVie 447.56 Bn 440.99 Bn 12.70 Bn 64.89 Bn
3 Merck 364.58 Bn 357.44 Bn 12.21 Bn 159.97 Bn
4 Novartis Ag 268.98 Bn 261.29 Bn 11.24 Bn 51.53 Bn
5 Pfizer 158.03 Bn 146.33 Bn 10.94 Bn 148.69 Bn
6 Sanofi 52.29 Bn 44.91 Bn 10.79 Bn 106.05 Bn
7 Revolution Medicines 43.18 Bn 43.18 Bn - -
8 Incyte 25.12 Bn 20.58 Bn 1.57 Bn 6.38 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Can-Fite BioPharma 1.83 Mn -1.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 29.14 Mn